Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This is a treatment guideline for an unrelated umbilical cord blood transplant (UCBT) using a
myeloablative preparative regimen for the treatment of hematological diseases, including, but
not limited to acute leukemias. The myeloablative preparative regimen will consist of
cyclophosphamide (CY), fludarabine (FLU) and fractionated total body irradiation (TBI).